Arca Pharmaceutical Index Performance
| DRG Index | 973.99 11.45 1.16% |
The index owns a Beta (Systematic Risk) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and ARCA Pharmaceutical are completely uncorrelated.
ARCA Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 111,233 in ARCA Pharmaceutical on September 12, 2024 and sell it today you would lose (13,834) from holding ARCA Pharmaceutical or give up 12.44% of portfolio value over 90 days. ARCA Pharmaceutical is generating negative expected returns and assumes 0.7843% volatility on return distribution over the 90 days horizon. Simply put, 6% of indexs are less volatile than ARCA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ARCA Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ARCA Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of indexs, such as ARCA Pharmaceutical, and traders can use it to determine the average amount a ARCA Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2646
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DRG |
Estimated Market Risk
| 0.78 actual daily | 6 94% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ARCA Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ARCA Pharmaceutical by adding ARCA Pharmaceutical to a well-diversified portfolio.
| ARCA Pharmaceutical generated a negative expected return over the last 90 days |